Volume 59, Issue 4, Pages (April 2011)

Slides:

Advertisements

Similar presentations

Volume 55, Issue 1, Pages 1-8 (January 2009)

Advertisements

The PSA Era is not Over for Prostate Cancer

Volume 50, Issue 1, Pages (July 2006)

Volume 52, Issue 1, Pages (July 2007)

Volume 64, Issue 3, Pages (September 2013)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Maurizio Brausi, Federica Rizzi, Saverio Bettuzzi European Urology

Volume 70, Issue 1, Pages (July 2016)

Testosterone Therapy in Men With Prostate Cancer

Global Trends in Testicular Cancer Incidence and Mortality

Volume 56, Issue 6, Pages (December 2009)

Volume 60, Issue 1, Pages (July 2011)

Volume 67, Issue 1, Pages (January 2015)

Volume 70, Issue 6, Pages (December 2016)

Volume 53, Issue 5, Pages (May 2008)

Lymphadenectomy in the Surgical Management of Penile Cancer

Volume 57, Issue 6, Pages (June 2010)

Volume 66, Issue 6, Pages (December 2014)

Volume 61, Issue 2, Pages (February 2012)

Prostate Cancer Epidemic in Sight?

Volume 52, Issue 4, Pages (October 2007)

Volume 72, Issue 5, Pages (November 2017)

Volume 63, Issue 1, Pages (January 2013)

Volume 61, Issue 2, Pages (February 2012)

Volume 44, Issue 1, Pages (July 2003)

Volume 59, Issue 6, Pages (June 2011)

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

The Role of Surgery in Metastatic Bladder Cancer: A Systematic Review

European Urology Oncology

Ute Ganswindt, Arnulf Stenzl, Michael Bamberg, Claus Belka

Volume 53, Issue 4, Pages (April 2008)

Prostate Cancer Detection: A View of the Future

Volume 67, Issue 3, Pages (March 2015)

Volume 56, Issue 2, Pages (August 2009)

Volume 70, Issue 4, Pages (October 2016)

Low-risk Prostate Cancer: Identification, Management, and Outcomes

Volume 69, Issue 6, Pages (June 2016)

Volume 52, Issue 3, Pages (September 2007)

Volume 70, Issue 1, Pages (July 2016)

Volume 70, Issue 5, Pages (November 2016)

Counselling the Prostate Cancer Patient

Active Surveillance for Prostate Cancer in a Real-life Cohort: Comparing Outcomes for PRIAS-eligible and PRIAS-ineligible Patients Timo F.W. Soeterik,

Prostate Cancer Epidemic in Sight?

The PSA Era is not Over for Prostate Cancer

Volume 53, Issue 2, Pages (February 2008)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 53, Issue 6, Pages (June 2008)

Volume 66, Issue 2, Pages (August 2014)

Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review Sven van.

Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia

Tillmann Loch, Pat Fox Fulgham European Urology

Volume 50, Issue 5, Pages (November 2006)

Volume 53, Issue 6, Pages (June 2008)

CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System

Volume 52, Issue 6, Pages (December 2007)

Volume 71, Issue 5, Pages (May 2017)

Testicular Cancer Variations in Time and Space in Europe

Insights into the Relationships between Prostatic Disorders and Their Potential Impact on Future Urologic Practice Claus Roehrborn European Urology.

Maurizio Brausi, Federica Rizzi, Saverio Bettuzzi European Urology

European Urology is “Your” Journal

A Multidisciplinary Team Approach for the Optimal Clinical Management of Metastatic Hormone-Refractory Prostate Cancer—Case Study John Fitzpatrick European.

Volume 68, Issue 5, Pages (November 2015)

Volume 54, Issue 1, Pages (July 2008)

Edith Canby-Hagino, Javier Hernandez, Timothy C. Brand, Ian Thompson

Volume 53, Issue 2, Pages (February 2008)

Early Single-Instillation Chemotherapy Has No Real Benefit and Should Be Abandoned in Non–Muscle-Invasive Bladder Cancer Sten Holmäng European Urology.

Volume 67, Issue 4, Pages (April 2015)

Ian W. Mills, Anna Crossland, Anup Patel, Henrikas Ramonas

Quality of life: An outcomes perspective

Volume 51, Issue 5, Pages (May 2007)

Presentation transcript:

Volume 59, Issue 4, Pages 509-514 (April 2011) Impact of 5α-Reductase Inhibitors on Men Followed by Active Surveillance for Prostate Cancer Antonio Finelli, Greg Trottier, Nathan Lawrentschuk, Robert Sowerby, Alexandre R. Zlotta, Lenny Radomski, Narhari Timilshina, Andrew Evans, Theodorus H. van der Kwast, Ants Toi, Micheal A.S. Jewett, John Trachtenberg, Neil E. Fleshner European Urology Volume 59, Issue 4, Pages 509-514 (April 2011) DOI: 10.1016/j.eururo.2010.12.018 Copyright © 2011 Terms and Conditions

Fig. 1 Kaplan-Meier analysis of (A) time to pathologic progression and (B) time to active treatment for patients on active surveillance for prostate cancer who are taking a 5α-reductase inhibitor (5-ARI) or not. European Urology 2011 59, 509-514DOI: (10.1016/j.eururo.2010.12.018) Copyright © 2011 Terms and Conditions